Skip to main content
[Translate to English:]

Novo Nordisk Pharma GmbH

Dr. Robert Haustein, Senior Manager Govermental Affairs, Head of Capital Office, Novo Nordisk Pharma GmbH

 

1. Describe your company in a Tweet! 

Novo Nordisk is a global leader in healthcare, founded in 1923 and headquartered in Denmark. We drive change with the goal of defeating diabetes and other serious chronic diseases such as obesity and rare blood and metabolic disorders. To do this, we are working on breakthrough scientific innovations to the point of curing diseases. We promote access to our products for patients worldwide and are actively engaged in prevention. Novo Nordisk employs around 45,000 people in 80 countries and markets its products in around 170 countries. Around 480 employees work at the German headquarters in Mainz.

 

2. Why do you get involved as a Berlin Partner? 

As an internationally active company with Danish roots, we are convinced of Berlin and its importance for the healthcare industry in Germany and Europe.

 

Exclusive information for Berlin-Partners

Photocredit: © Novo Nordisk

TeilenShare

Weitere
Informationen
Further
Information

FIBE 2025

09.04.2025
From 9 to 10 April 2025, the FIBE Festival will once again demonstrate Berlin’s strength as a leading FinTech location

Read more

How circular are Berlin companies?

08.04.2025
In an interview: Robin Bruck, Manager Climate Protection and Circular Economy at Berlin Partner

Read more

Women in Aerospace

03.04.2025
Empowering all Women, in Space and on Earth: This is the motto of the women’s network of the aerospace industry.

Read more

Berlin is knorke: Next generation battery cells

31.03.2025
For a sustainable future: new battery technologies from Berlin

Read more

Europe’s largest makerspace

21.03.2025
MotionLab.Berlin is the new operator of Europe’s largest makerspace, which is being built on the ringberlin model campus in Mariendorf.

Read more

Startup Pitch 2025

20.03.2025
20 selected startups presented their business ideas to high-calibre investors in the Rotes Rathaus.

Read more